ITGB4 has been proposed as a potential biomarker for pancreatic adenocarcinoma due to its overexpression and altered localization compared to normal and chronically inflamed pancreatic tissues [48]. This evidence concerns the gene ITGB4 and pancreatic adenocarcinoma.